Skip to main content
. 2012 Jul 10;74(2):284–295. doi: 10.1111/j.1365-2125.2012.04208.x

Table A2.

Summary of time to event parameters for the final models RSE (in parentheses) is the relative standard error calculated as a percentage of the parameter point estimate

Parameters Parameter estimates (RSE %)
Deaths at EOT n= 98 Disability n= 364 Cognitive impairment n= 89 Depression n= 183
Baseline hazard 1.28 × 10−5 2.45 × 10−3 1.39 × 10−4 5.79 × 10−2
β0, u year−1 (18) (58) (10) (27)
Time 0.127 −0.250 −0.385
βtime, year−1 (38) (20) (15)
Age at study entry 0.0649 0.0257 0.075
βage, year−1 (10) (48) (4)
Selegiline 0.925 −0.451 −0.466
βDP, at 10 mg day−1 (28) (35) (37)
Levodopa
βLD, at 300 mg day−1
Disease status measure UPDRS UPDRS PIGD UPDRS
βDS, per unit 0.0336 0.101 0.147 0.036
(10) (9) (28) (18)

EOT, end of trial; UPDRS, United Parkinson's Disease Rating Scale; PIGD, postural instability gait disorder score.

The death hazard model h, as a function of time is:

h(time) =β0 * exp(βtime * time +βage * Age0DP * DP +βLD * LD +βDS * status(time))

Age0 is age at study entry; DP is 1 when selegiline is used, LD is 1 when levodopa is used otherwise DP and LD are zero; Status(time) is the predicted disease status e.g. UPDRS, at time since study entry.